title: [Genetic factors influencing efficacy of clopidogrel treatment].
authors.affiliation: Katedra i Zakład Farmacji Fizycznej i Farmakokinetyki, Uniwersytet Medyczny im. Karola Marcinkowskiego, Poznań, Poland. mkaraz@ump.edu.pl
authors.forename: Marta
authors.initials: M
authors.lastname: Karaźniewicz-Łada
authors.forename: Dorota
authors.initials: D
authors.lastname: Danielak
authors.forename: Franciszek
authors.initials: F
authors.lastname: Główka
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D043303:Aryldialkylphosphatase / Q000235:genetics*; D001792:Blood Platelets / Q000378:metabolism; D000077144:Clopidogrel; D004351:Drug Resistance / Q000235:genetics*; D006801:Humans; D008099:Liver / Q000201:enzymology; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics*; D015539:Platelet Activation / Q000235:genetics*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011110:Polymorphism, Genetic; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; D043303:Aryldialkylphosphatase; D013988:Ticlopidine